The Board of Queensland Bauxite (ASX:QBL) is delighted to announce that Mineral Development License approval has been progressed for the South Johnstone Bauxite Project at Camp Creek in Queensland with the important decision received today from the DEHP to approve the amendment to our previous Environmental Authority, to allow for the work programme intended under the MDL.
Anatara Lifesciences Ltd (ASX:ANR) is pleased to announce that global animal health company, Zoetis Inc. has exercised its option to negotiate a commercial agreement for the worldwide development, distribution and marketing of Detach(R), with terms to be agreed.
Queensland Bauxite Ltd (ASX:QBL) is delighted to announce that its subsidiary company Medical Cannabis Limited has reported success with its previously announced winter trial crops.
(NetworkNewsWire) For preclinical oncology biopharma Moleculin Biotech, Inc. (NASDAQ:MBRX), the quest to deliver potentially revolutionary anti-cancer drugs to the market is enkindled by a close association with The University of Texas MD Anderson Cancer Center.
During the June Quarter 2017, Queensland Bauxite Limited (ASX:QBL) continued to press to progress the development of its flagship South Johnstone DSO bauxite project in northern Queensland, with the Company aiming to generate positive net cash flows in the short term through the commencement of DSO bauxite production and shipping.
This is a reminder notice that your options to subscribe for ordinary fully paid shares in Queensland Bauxite Limited (ASX:QBL) will expire at 5:00pm Australian Western Standard Time on 31 July 2017.
Queensland Bauxite Ltd (ASX:QBL) is excited to announce that Medical Cannabis Limited has confirmed successful germination and growth rates of its pioneering winter Cannabis crop.
